Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV002007370 | SCV002230772 | pathogenic | Tuberous sclerosis 2 | 2021-05-09 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Cys206Trpfs*10) in the TSC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TSC2 are known to be pathogenic (PMID: 10205261, 17304050). This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with TSC2-related conditions. For these reasons, this variant has been classified as Pathogenic. |
| Myriad Genetics, |
RCV002007370 | SCV003806601 | pathogenic | Tuberous sclerosis 2 | 2023-01-18 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. |